To sum up, our results provide the first evidence for the in vivo requirement of caspase-1/11 as an important player not only for mounting an appropriate type-1 adaptive immune response for the control of parasite burden in the liver, but also in promoting its inflammation and hence the progression of this parasite infection. The gene discussed is CASP1; the disease is parasitic infectious disease.